Capital Health Medical Center – Hopewell is now a NCI Community Oncology Research Program (NCORP) affiliate site of the Atlantic Health Cancer Consortium (AHCC).
As a participating site, Capital Health Cancer Center will now offer residents in the greater Mercer and Bucks County region access to new and innovative NCI-sponsored clinical trials in the cancer prevention and control, screening, care delivery, and treatment areas.
As part of AHCC NCORP, Capital Health Cancer Center’s team of providers and researchers will help patients gain access to clinical trials across a broad range of cancer care benchmarks, including symptom management, prevention, screening, surveillance, care delivery and quality of life.
The NCORP network’s diversity in patient age, race, and geographic location, provides a natural laboratory for developing improved strategies for cancer prevention, more efficient cancer trials, and a better balance between the risks and benefits of interventions.
To help connect patients to advanced care options, research staff at Capital Health Cancer Center will select trials from the NCORP research portfolio that may benefit the Center’s patient population.
Appropriate studies are then presented to oncology physician teams to determine if they are good fits for specific patients. When a match is made, a primary investigator is appointed, and Capital Health research staff open the trial for Capital Health Cancer Center patients.
To learn more about open clinical trials at Capital Health Cancer Center, visit www.capitalhealthcancer.org/ncorp, sign-up for email updates or call 609-537-6363 to schedule a consultation with one of our physicians.